PT Bundamedik Tbk (ISX:BMHS) Ending Cash Position: Rp835,794 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:BMHS PT Bundamedik Tbk ISX:BMHS
76 GF Score
Price Rp199.00
GF Value Rp279.06
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Ending Cash Position?

PT Bundamedik Tbk ISX:BMHS +1.01% 76 Ending Cash Position is Rp835,794 Mil as of Jun. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 76/100 and a GF Value™ of Rp279.06 (Modestly Undervalued). The stock has 6 warning signs investors should review.

PT Bundamedik Tbk's Ending Cash Position for the quarter that ended in Jun. 2026 was Rp835,794 Mil.

PT Bundamedik Tbk's quarterly Ending Cash Position increased from Dec. 2025 (Rp826,585 Mil) to Mar. 2026 (Rp833,565 Mil) and increased from Mar. 2026 (Rp833,565 Mil) to Jun. 2026 (Rp835,794 Mil).

PT Bundamedik Tbk's annual Ending Cash Position increased from Dec. 2023 (Rp622,058 Mil) to Dec. 2024 (Rp783,332 Mil) and increased from Dec. 2024 (Rp783,332 Mil) to Dec. 2025 (Rp826,585 Mil).

PT Bundamedik Tbk Ending Cash Position Related Terms

PT Bundamedik Tbk Ending Cash Position Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Ending Cash Position Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 829,761.01 629,277.67 622,058.01 783,332.06 826,584.74

PT Bundamedik Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 761,279.32 810,679.05 826,584.74 833,564.90 835,794.41
ISX:BMHS
76GF Score
PT Bundamedik Tbk ISX:BMHS
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PT Bundamedik Tbk's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=783332.056074+43252.685834
=826,585

PT Bundamedik Tbk's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=833564.898928+2229.510596
=835,794

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of Rp835,794 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a Ending Cash Position of Rp835,794 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Ending Cash Position too high?
PT Bundamedik Tbk's current Ending Cash Position is Rp835,794 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Ending Cash Position compare to HCA and THC?
PT Bundamedik Tbk's Ending Cash Position of Rp835,794 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Ending Cash Position is Rp835,794 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp279.06, compared to a current price of Rp199.00 — trading 28.7% below its estimated fair value. The current Ending Cash Position is Rp835,794 Mil. PT Bundamedik Tbk's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Ending Cash Position is Rp835,794 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp199.00 is trading 28.7% below its estimated GF Value™ of Rp279.06. GuruFocus considers PT Bundamedik Tbk to be Modestly Undervalued.

Key valuation signals for ISX:BMHS:

  • Ending Cash Position: Rp835,794 Mil
  • GF Value™: Rp279.06 vs. price of Rp199.00 (28.7% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
76GF Score

Get the complete analysis for ISX:BMHS

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp199.00
Price
Rp279.06
GF Value